Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 255

1.

Autocrine and paracrine chemokine receptor 7 activation in head and neck cancer: implications for therapy.

Wang J, Seethala RR, Zhang Q, Gooding W, van Waes C, Hasegawa H, Ferris RL.

J Natl Cancer Inst. 2008 Apr 2;100(7):502-12. doi: 10.1093/jnci/djn059. Epub 2008 Mar 25.

PMID:
18364504
2.

Chemokine receptor 7 activates phosphoinositide-3 kinase-mediated invasive and prosurvival pathways in head and neck cancer cells independent of EGFR.

Wang J, Zhang X, Thomas SM, Grandis JR, Wells A, Chen ZG, Ferris RL.

Oncogene. 2005 Sep 1;24(38):5897-904.

PMID:
16007209
3.

CCL19-induced chemokine receptor 7 activates the phosphoinositide-3 kinase-mediated invasive pathway through Cdc42 in metastatic squamous cell carcinoma of the head and neck.

Zhao ZJ, Liu FY, Li P, Ding X, Zong ZH, Sun CF.

Oncol Rep. 2011 Mar;25(3):729-37. doi: 10.3892/or.2010.1109. Epub 2010 Dec 14.

PMID:
21165582
4.

PKCα take part in CCR7/NF-κB autocrine signaling loop in CCR7-positive squamous cell carcinoma of head and neck.

Zhen-jin Z, Peng L, Fa-yu L, Liyan S, Chang-fu S.

Mol Cell Biochem. 2011 Nov;357(1-2):181-7. doi: 10.1007/s11010-011-0888-0. Epub 2011 Jul 7.

PMID:
21735098
5.

Chemokine receptor 7 promotes tumor migration and invasiveness via the RhoA/ROCK pathway in metastatic squamous cell carcinoma of the head and neck.

Xu Z, Zheng X, Yang L, Liu F, Zhang E, Duan W, Bai S, Safdar J, Li Z, Sun C.

Oncol Rep. 2015 Feb;33(2):849-55. doi: 10.3892/or.2014.3631. Epub 2014 Nov 27.

PMID:
25434638
6.

Mammalian target of rapamycin (mTOR) is involved in the survival of cells mediated by chemokine receptor 7 through PI3K/Akt in metastatic squamous cell carcinoma of the head and neck.

Liu FY, Zhao ZJ, Li P, Ding X, Zong ZH, Sun CF.

Br J Oral Maxillofac Surg. 2010 Jun;48(4):291-6. doi: 10.1016/j.bjoms.2009.06.007. Epub 2009 Jul 16.

PMID:
19615795
7.

Chemokine receptor 7 (CCR7) gene expression is regulated by NF-κB and activator protein 1 (AP1) in metastatic squamous cell carcinoma of head and neck (SCCHN).

Mburu YK, Egloff AM, Walker WH, Wang L, Seethala RR, van Waes C, Ferris RL.

J Biol Chem. 2012 Jan 27;287(5):3581-90. doi: 10.1074/jbc.M111.294876. Epub 2011 Dec 12.

8.

Analysis of migratory and prosurvival pathways induced by the homeostatic chemokines CCL19 and CCL21 in B-cell chronic lymphocytic leukemia.

Cuesta-Mateos C, López-Giral S, Alfonso-Pérez M, de Soria VG, Loscertales J, Guasch-Vidal S, Beltrán AE, Zapata JM, Muñoz-Calleja C.

Exp Hematol. 2010 Sep;38(9):756-64, 764.e1-4. doi: 10.1016/j.exphem.2010.05.003. Epub 2010 May 19.

PMID:
20488224
9.

Human β-defensin 3 promotes NF-κB-mediated CCR7 expression and anti-apoptotic signals in squamous cell carcinoma of the head and neck.

Mburu YK, Abe K, Ferris LK, Sarkar SN, Ferris RL.

Carcinogenesis. 2011 Feb;32(2):168-74. doi: 10.1093/carcin/bgq236. Epub 2010 Nov 11.

10.

Chemokine receptor 7 enhances cell chemotaxis and migration of metastatic squamous cell carcinoma of head and neck through activation of matrix metalloproteinase-9.

Guo N, Liu F, Yang L, Huang J, Ding X, Sun C.

Oncol Rep. 2014 Aug;32(2):794-800. doi: 10.3892/or.2014.3242. Epub 2014 Jun 6.

PMID:
24912620
11.

The expression of chemokines CCL19, CCL21 and their receptor CCR7 in oral squamous cell carcinoma and its relevance to cervical lymph node metastasis.

Oliveira-Neto HH, de Souza PP, da Silva MR, Mendonça EF, Silva TA, Batista AC.

Tumour Biol. 2013 Feb;34(1):65-70. doi: 10.1007/s13277-012-0511-3. Epub 2012 Sep 14.

PMID:
22976543
12.

CCR7 mediates inflammation-associated tumor progression.

Mburu YK, Wang J, Wood MA, Walker WH, Ferris RL.

Immunol Res. 2006;36(1-3):61-72. Review.

PMID:
17337767
13.

NF-κB participates in chemokine receptor 7-mediated cell survival in metastatic squamous cell carcinoma of the head and neck.

Liu FY, Zhao ZJ, Li P, Ding X, Guo N, Yang LL, Zong ZH, Sun CF.

Oncol Rep. 2011 Feb;25(2):383-91. doi: 10.3892/or.2010.1090. Epub 2010 Dec 9.

PMID:
21165563
14.

Expression of chemokine receptor CCR7 is associated with cervical lymph node metastasis of oral squamous cell carcinoma.

Shang ZJ, Liu K, Shao Z.

Oral Oncol. 2009 Jun;45(6):480-5. doi: 10.1016/j.oraloncology.2008.06.005. Epub 2008 Aug 26.

PMID:
18752985
15.

Ectopic lymphoid tissue alters the chemokine gradient, increases lymphocyte retention and exacerbates murine ileitis.

McNamee EN, Masterson JC, Jedlicka P, Collins CB, Williams IR, Rivera-Nieves J.

Gut. 2013 Jan;62(1):53-62. doi: 10.1136/gutjnl-2011-301272. Epub 2012 Jan 20.

16.

Baicalin attenuates inflammation in mice with OVA-induced asthma by inhibiting NF-κB and suppressing CCR7/CCL19/CCL21.

Liu J, Wei Y, Luo Q, Xu F, Zhao Z, Zhang H, Lu L, Sun J, Liu F, Du X, Li M, Wei K, Dong J.

Int J Mol Med. 2016 Nov;38(5):1541-1548. doi: 10.3892/ijmm.2016.2743. Epub 2016 Sep 21.

PMID:
27666000
17.

Gastrin-releasing peptide receptor-mediated autocrine growth in squamous cell carcinoma of the head and neck.

Lango MN, Dyer KF, Lui VW, Gooding WE, Gubish C, Siegfried JM, Grandis JR.

J Natl Cancer Inst. 2002 Mar 6;94(5):375-83.

PMID:
11880476
18.

Decreased STAT1 expression by promoter methylation in squamous cell carcinogenesis.

Xi S, Dyer KF, Kimak M, Zhang Q, Gooding WE, Chaillet JR, Chai RL, Ferrell RE, Zamboni B, Hunt J, Grandis JR.

J Natl Cancer Inst. 2006 Feb 1;98(3):181-9.

PMID:
16449678
19.

Immunohistochemical analysis of phosphotyrosine signal transducer and activator of transcription 3 and epidermal growth factor receptor autocrine signaling pathways in head and neck cancers and metastatic lymph nodes.

Seethala RR, Gooding WE, Handler PN, Collins B, Zhang Q, Siegfried JM, Grandis JR.

Clin Cancer Res. 2008 Mar 1;14(5):1303-9. doi: 10.1158/1078-0432.CCR-07-1543. Erratum in: Clin Cancer Res. 2008 Apr 1;14(7):2247.

20.

The role of CCL21/CCR7 chemokine axis in breast cancer-induced lymphangiogenesis.

Tutunea-Fatan E, Majumder M, Xin X, Lala PK.

Mol Cancer. 2015 Feb 10;14:35. doi: 10.1186/s12943-015-0306-4.

Supplemental Content

Support Center